These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 20622738)
1. Elvis is back: musical hallucinations in a Parkinson disease patient. Mittal M; Giron LT South Med J; 2010 Aug; 103(8):837-41. PubMed ID: 20622738 [TBL] [Abstract][Full Text] [Related]
2. Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease. Zoldan J; Friedberg G; Weizman A; Melamed E Adv Neurol; 1996; 69():541-4. PubMed ID: 8615178 [No Abstract] [Full Text] [Related]
3. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients. Goetz CG; Wuu J; Curgian L; Leurgans S Mov Disord; 2006 Feb; 21(2):267-70. PubMed ID: 16161144 [TBL] [Abstract][Full Text] [Related]
4. Patients with PD describe hallucinations in new video with Dr. Friedman. Korr M R I Med J (2013); 2014 Oct; 97(10):55. PubMed ID: 25271664 [No Abstract] [Full Text] [Related]
6. Auditory musical hallucinations associated with extended-release pramipexole in an elderly patient with Parkinson's disease. Kataoka H; Ueno S Medicine (Baltimore); 2014 Dec; 93(27):e251. PubMed ID: 25501095 [TBL] [Abstract][Full Text] [Related]
7. Hallucinations in Parkinson's disease. Korczyn AD Lancet; 2001 Sep; 358(9287):1031-2. PubMed ID: 11589931 [No Abstract] [Full Text] [Related]
8. Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease. Merims D; Shabtai H; Korczyn AD; Peretz C; Weizman N; Giladi N J Neural Transm (Vienna); 2004 Oct; 111(10-11):1447-53. PubMed ID: 15480845 [TBL] [Abstract][Full Text] [Related]
9. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients. Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620 [TBL] [Abstract][Full Text] [Related]
10. Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease. Gondim Fde A; Costa HA; Taunay TC; de Oliveira GR; Ferreira JM; Rola FH Mov Disord; 2010 Jul; 25(10):1505-6. PubMed ID: 20629118 [No Abstract] [Full Text] [Related]
11. Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease. Matsui H; Udaka F; Tamura A; Oda M; Kubori T; Nishinaka K; Kameyama M J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):36-40. PubMed ID: 16449759 [TBL] [Abstract][Full Text] [Related]
12. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report. Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968 [TBL] [Abstract][Full Text] [Related]
13. Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations. van Laar T; Postma AG; Drent M Parkinsonism Relat Disord; 2010 Jan; 16(1):71-2. PubMed ID: 19524477 [No Abstract] [Full Text] [Related]